Characteristic clinical presentation and CSF biomarker pattern in cerebral small vessel disease

Anders Wallin1, Annika Ohrfelt, Maria Bjerke

  • 1Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden. anders.wallin@neuro.gu.se

Insights

Maintaining cognitive function is vital for independence. Small vessel disease, a silent precursor to stroke and dementia, involves brain arteriolosclerosis and may be detected through biochemical markers.

Area of Science:

  • Neurology
  • Vascular Biology
  • Biochemistry

Background:

  • Cognitive functions are essential for independent living, with dementia and stroke being major causes of disability.
  • Stroke often results from long-term, asymptomatic vessel wall disease, particularly arteriolosclerosis affecting brain arterioles.
  • Arteriolosclerosis, influenced by aging, hypertension, diabetes, and genetics, contributes to white matter changes and ischemic damage.

Purpose of the Study:

  • To explore the role of arteriolosclerosis in cognitive decline and disability.
  • To investigate the pathological mechanisms of small vessel disease in the brain.
  • To identify potential early biochemical indicators of small vessel disease and its progression.

Main Methods:

  • Analysis of pathological processes in arteriolosclerotic blood vessels.
  • Investigation of enzyme involvement in demyelination, blood-brain barrier integrity, and repair mechanisms (angiogenesis, neurogenesis).
  • Focus on biochemical changes reflecting vascular wall remodeling and tissue damage.

Main Results:

  • Arteriolosclerosis leads to lumen constriction and impaired cerebral blood flow regulation.
  • Associated inflammation and matrix remodeling contribute to demyelination and blood-brain barrier opening.
  • Enzymes involved in these vascular processes also play roles in neurogenesis and angiogenesis.

Conclusions:

  • Biochemical changes associated with arteriolosclerosis may serve as early indicators of small vessel disease.
  • Understanding these mechanisms enhances knowledge of disease characteristics.
  • Biochemical markers could enable monitoring of disease-modifying treatments for small vessel disease.

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...